Targeting p300/CBP axis in lethal prostate cancer. Targeting p300/CBP axis in lethal prostate cancer
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA682218
下载链接
链接失效反馈官方服务：
资源简介：
Treating CRPC remains challenging due to persistent AR signaling. Inhibiting transcriptional AR co-activators is an attractive therapeutic strategy. CCS1477, an inhibitor of p300/CBP, alters the transcriptome of Prostate Cancer cell models Overall design: Transcriptional Alterations in prostate cancer models after treatment with p300/CBP inhibitor, BET inhibitor, or control
创建时间：
2020-12-02
